Differential Modulation of the Ileal Bile Acid Transporter ASBT by Fatty Acids
- 1Division of Gastroenterology & Hepatology, University of Illinois Chicago, Chicago, IL 60612, USA
- 2Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, MN 55905, USA
- 3Jesse Brown VA Medical Center, Chicago, IL 60612, USA
Abstract
The ileal ASBT bile acid transporter is a critical mediator of bile acid and cholesterol homeostasis and is modulated by fatty acids via S-acylation. We investigated mechanisms underlying differential regulation of ASBT by saturated and polyunsaturated fatty acids. Using a prenylation mimetic with a CAAX box at the C-terminus of ASBT, we showed that transport activity in transfected HEK293 cells increased significantly, suggesting that direct attachment of a saturated fatty acid stimulates ASBT function. Furthermore, siRNA-mediated attenuation of DHHC21 acyltransferase expression reduced ASBT S-acylation and its function, demonstrating DHHC21 as a positive regulator of ASBT function. Conversely, treatment with omega-3 polyunsaturated fatty acids (n-3 PUFAs), like eicosapentaenoic acid (EPA), reduced ASBT function in HEK293 cells. Supplementation of fish oil, as a source of n-3 PUFAs, to a high-fat, high-cholesterol diet fed to C57BL6/J mice protected them against diet-induced hepatic steatosis, along with reduced bile acid absorption consistent with the inhibition of ASBT. This was supported by increased fecal bile acids, decreased ileal bile acid-stimulated gene expression, and increased hepatic bile acid synthesis-related gene expression. Metabolic labeling with alkyne-EPA in HEK293 cells showed, for the first time, direct binding of this n-3 PUFA to ASBT. Unlike palmitate modification, EPA binding was highly resistant to hydroxylamine retrieval, indicating a mechanism distinct from S-acylation. Our data unraveled a novel role for DHHC21 in regulating ASBT and provided evidence for distinct mechanisms by which saturated palmitate and polyunsaturated EPA fatty acids bind ASBT. The direct effect on ASBT and inhibition of bile acid absorption may partly contribute to the protective effects of n-3 PUFAs on the liver.
Related
- Pharmacological analysis of negative allosteric modulation of the α7 nicotinic receptor by polyunsaturated free fatty acids
- Tracing of 13C-labeled fatty acids indicate the lack of linoleic acid synthesis in mammalian cells
- Effect of Pure EPA on Erythrocyte Membrane Fatty Acids During Supplementation and Washout: A Randomized Controlled Trial
- Circulating arginine–nitric oxide pathway metabolites and nitrated fatty acids in relation to pathological features of colorectal cancer
- Exogenous antimicrobial straight-chain unsaturated fatty acids promote low-temperature growth of Staphylococcus aureus
BibTeX
@article{malhotra2026differential,
title = {{Differential Modulation of the Ileal Bile Acid Transporter ASBT by Fatty Acids}},
author = {Pooja Malhotra and Zeba Farooqui and Alexander Ticho and Shane Comiskey and Aisha Qazi and Nathan Calzadilla and Ricardo J. Suarez and Ravinder K. Gill and Waddah A. Alrefai},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms27219920},
url = {https://www.mdpi.com/1422-0067/27/21/9920},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Differential Modulation of the Ileal Bile Acid Transporter ASBT by Fatty Acids
AU - Pooja Malhotra
AU - Zeba Farooqui
AU - Alexander Ticho
AU - Shane Comiskey
AU - Aisha Qazi
AU - Nathan Calzadilla
AU - Ricardo J. Suarez
AU - Ravinder K. Gill
AU - Waddah A. Alrefai
PY - 2026
DA - 2026/11/05
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219920
UR - https://www.mdpi.com/1422-0067/27/21/9920
AB - The ileal ASBT bile acid transporter is a critical mediator of bile acid and cholesterol homeostasis and is modulated by fatty acids via S-acylation. We investigated mechanisms underlying differential regulation of ASBT by saturated and polyunsaturated fatty acids. Using a prenylation mimetic with a CAAX box at the C-terminus of ASBT, we showed that transport activity in transfected HEK293 cells increased significantly, suggesting that direct attachment of a saturated fatty acid stimulates ASBT function. Furthermore, siRNA-mediated attenuation of DHHC21 acyltransferase expression reduced ASBT S-acylation and its function, demonstrating DHHC21 as a positive regulator of ASBT function. Conversely, treatment with omega-3 polyunsaturated fatty acids (n-3 PUFAs), like eicosapentaenoic acid (EPA), reduced ASBT function in HEK293 cells. Supplementation of fish oil, as a source of n-3 PUFAs, to a high-fat, high-cholesterol diet fed to C57BL6/J mice protected them against diet-induced hepatic steatosis, along with reduced bile acid absorption consistent with the inhibition of ASBT. This was supported by increased fecal bile acids, decreased ileal bile acid-stimulated gene expression, and increased hepatic bile acid synthesis-related gene expression. Metabolic labeling with alkyne-EPA in HEK293 cells showed, for the first time, direct binding of this n-3 PUFA to ASBT. Unlike palmitate modification, EPA binding was highly resistant to hydroxylamine retrieval, indicating a mechanism distinct from S-acylation. Our data unraveled a novel role for DHHC21 in regulating ASBT and provided evidence for distinct mechanisms by which saturated palmitate and polyunsaturated EPA fatty acids bind ASBT. The direct effect on ASBT and inhibition of bile acid absorption may partly contribute to the protective effects of n-3 PUFAs on the liver.
SN - 1422-0067
ER -